Lagging rival Neurocrine, Teva preps ad campaign in tardive dyskinesia

Teva is joining the marketing push in tardive dyskinesia with its first consumer campaign for Austedo, executives said Wednesday..

Teva’s campaign will be the second tardive dyskinesia effort in market. Rival Neurocrine Biosciences' unbranded awareness effort “Talk About TD” has been running on TV and digital since 2019.